Endocrine function after bone marrow transplantation for thalassemia. 1991

M Galimberti, and V De Sanctis, and G Lucarelli, and P Polchi, and E Angelucci, and D Baronciani, and C Vullo, and B Bagni
Divisione di Ematologia, Ospedale di Pesaro, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D011628 Puberty, Delayed The lack of development of SEXUAL MATURATION in boys and girls at a chronological age that is 2.5 standard deviations above the mean age at onset of PUBERTY in a population. Delayed puberty can be classified by defects in the hypothalamic LHRH pulse generator, the PITUITARY GLAND, or the GONADS. These patients will undergo spontaneous but delayed puberty whereas patients with SEXUAL INFANTILISM will not. Delayed Puberty
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004700 Endocrine System Diseases Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES. Endocrine Diseases,Diseases of Endocrine System,Disease, Endocrine,Disease, Endocrine System,Diseases, Endocrine,Diseases, Endocrine System,Endocrine Disease,Endocrine System Disease,System Disease, Endocrine,System Diseases, Endocrine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Galimberti, and V De Sanctis, and G Lucarelli, and P Polchi, and E Angelucci, and D Baronciani, and C Vullo, and B Bagni
February 1995, Bone marrow transplantation,
M Galimberti, and V De Sanctis, and G Lucarelli, and P Polchi, and E Angelucci, and D Baronciani, and C Vullo, and B Bagni
January 2004, Pediatric hematology and oncology,
M Galimberti, and V De Sanctis, and G Lucarelli, and P Polchi, and E Angelucci, and D Baronciani, and C Vullo, and B Bagni
April 1995, Clinical endocrinology,
M Galimberti, and V De Sanctis, and G Lucarelli, and P Polchi, and E Angelucci, and D Baronciani, and C Vullo, and B Bagni
October 1987, The New England journal of medicine,
M Galimberti, and V De Sanctis, and G Lucarelli, and P Polchi, and E Angelucci, and D Baronciani, and C Vullo, and B Bagni
January 1993, Indian journal of pediatrics,
M Galimberti, and V De Sanctis, and G Lucarelli, and P Polchi, and E Angelucci, and D Baronciani, and C Vullo, and B Bagni
July 2002, Haematologica,
M Galimberti, and V De Sanctis, and G Lucarelli, and P Polchi, and E Angelucci, and D Baronciani, and C Vullo, and B Bagni
January 1993, Bone marrow transplantation,
M Galimberti, and V De Sanctis, and G Lucarelli, and P Polchi, and E Angelucci, and D Baronciani, and C Vullo, and B Bagni
January 1993, Bone marrow transplantation,
M Galimberti, and V De Sanctis, and G Lucarelli, and P Polchi, and E Angelucci, and D Baronciani, and C Vullo, and B Bagni
October 1999, Hematology/oncology clinics of North America,
M Galimberti, and V De Sanctis, and G Lucarelli, and P Polchi, and E Angelucci, and D Baronciani, and C Vullo, and B Bagni
June 1998, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!